Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Ken d’Entremont
|
| gptkbp:countryOfOperation |
gptkb:Canada
gptkb:Germany gptkb:United_States |
| gptkbp:focusesOn |
rare diseases
specialty pharmaceuticals |
| gptkbp:foundedYear |
2018
|
| gptkbp:headquartersLocation |
Montreal, Quebec, Canada
|
| https://www.w3.org/2000/01/rdf-schema#label |
Medexus Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:product |
Rasuvo
Treosulfan IXINITY Metopirone |
| gptkbp:stockExchange |
gptkb:TSX
|
| gptkbp:stockSymbol |
gptkb:MDP
|
| gptkbp:website |
https://www.medexus.com/
|
| gptkbp:bfsParent |
gptkb:Adele_Gulfo
|
| gptkbp:bfsLayer |
6
|